Navigation Links
Actinium Pharmaceuticals Clinical Results Featured at a United Nations Forum
Date:7/9/2013

NEW YORK, July 9, 2013 /PRNewswire/ -- Actinium Pharmaceuticals Inc. (OTCQB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for treatment of advanced cancers, announced that the Actinium Pharmaceuticals' clinical programs and platform technology were presented in Vienna, Austria, at a technical meeting at the International Atomic Energy Agency (IAEA). The presentation was delivered by Dr. David Scheinberg, Interim Director of the Sloan-Kettering Institute, research division of the Memorial Sloan-Kettering Cancer Center.

"There is increasing interest in the uses of alpha particle therapy around the world," said Dr. Scheinberg. "We now see scientists, clinicians, isotope manufacturers, government agencies and commercial companies collaborating to enable therapeutic advances of these agents against cancer." 

Dr. Scheinberg's presentation focused on Actinium Pharmaceuticals' drug candidates Actimab-A and Bismab for acute myeloid leukemia as well as applications of alpha immunotherapy in treatment of solid cancers. The IAEA meeting at the United Nations headquarters in Vienna, Austria, was a closed workshop entitled "Alpha Emitting Radionuclides and Radiopharmaceuticals for Therapy".

About Actimab - A
Actimab-A is a drug candidate construct made using Actinium Pharmaceuticals' proprietary patented technology for arming monoclonal antibodies with alpha emitters actinium-225 and bismuth-213.  Antibodies are used as high precision delivery systems that bring powerful alpha emitters into or immediately next to targeted cancer cells. Actimab-A consists of the Lintuzumab monoclonal antibody and actinium-225.

Actinium-225 decays by giving off high-energy alpha particles, which kill cancer cells. When actinium decays, it produces a series of daughter atoms, each of which giv
'/>"/>

SOURCE Actinium Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants
2. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
3. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
4. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
5. Actinium Pharmaceuticals, Inc. To Present at the 15th Annual BIO CEO Investor Conference
6. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
7. University of Pennsylvania joins Actinium Pharmaceuticals Multicenter Actimab-A Trial
8. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
9. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
10. Actinium Pharmaceuticals Announces New Round of Financing
11. Gerri Henwood Joins Actinium Pharmaceuticals as Chief Development Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015 Every year in ... with nearly 38,000 of those ending in ... a highly contagious disease, infects approximately 94,000 ... of these and more, not listed, are ... contact with other infectious individuals, contact with ...
(Date:3/2/2015)... SAN FRANCISCO, Calif. , March 2, 2015 ... for the treatment of cancer, today announced the ... of leading researchers and clinicians in the fields ... The new advisory boards will provide ... wholly owned pipeline of precision immunotherapies and Probody ...
(Date:3/2/2015)... , March 2, 2015   Mast Therapeutics, ... company, today announced preliminary findings from a randomized, ... model of chronic, stable heart failure produced by ... was to examine the effects of repeat intravenous ... and diastolic function. Consistent with ...
Breaking Medicine Technology:Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 2Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 3CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 2Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 4Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 5Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 6
... in mid 2010, the National Intrepid Center of Excellence ... care of military personnel and veterans suffering from traumatic brain ... ®, an advanced magnetoencephalography (MEG) device, NICoE plans to shed ... , TBI is a leading cause of sustained impairment in ...
... Ariz., Oct. 14 When it comes to slumping ... easy to point a finger at a shrinking sales ... new data from the 2009 Leadership Skills Survey, conducted ... http://www.gottochange.com ), indicates that the root of the ...
Cached Medicine Technology:National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta 2National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta 3Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 2Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 3
(Date:3/2/2015)... (PRWEB) March 02, 2015 Today the Brain ... Awareness Month, a time to recognize and support the more ... , Each year BIAA leads the nation in observing ... the month of March. The theme for the 2015 to ... campaign provides a platform for educating the general public about ...
(Date:3/2/2015)... NY (PRWEB) March 02, 2015 ... history of catalyzing private sector activities and investments ... has recently elected four new members to serve ... welcomes Dr. Paul Farmer, Chief Strategist and Co-founder ... at Harvard University; Dr. Huma Abbasi, General Manager ...
(Date:3/2/2015)... Ticket Down is a reputable source for ... This popular site has reduced all ticket prices and ... added savings. , Parrotheads in the Los Angeles area ... at the Hollywood Bowl for the first time since ... 22nd and it will be in conjunction with Buffett's ...
(Date:3/2/2015)... 02, 2015 While many hospitals have ... of the Civil Rights Act, the unique needs of ... are bringing light to the value of video remote ... nearly 1 in 20 U.S. children have LEP—a number ... some major cities.(1) Stratus Video Interpreting enables ...
(Date:3/2/2015)... 02, 2015 ZoomCare announced today ... American healthcare. Zoom will expand its Portland on-demand ... and advanced care studios delivering urgent care, primary ... specialty care and outpatient surgery. With its new ... almost all healthcare needs outside of hospitalization. , ...
Breaking Medicine News(10 mins):Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3
... fatty liver disease (NAFLD), which may soon be the ... significantly associated with worse transplant outcomes. In addition, a ... liver biopsy, which is more expensive and prone to ... an effective alternative to CT scan and MRI for ...
... ... Westmont of Morgan Hill offers a comfortable, quality lifestyle tailored to senior’s individual needs, ... to meet each resident’s individual requirements, while maintaining the highest level of dignity, privacy ... ...
... A research team led by Mayo Clinic physicians has ... than doubled risk for some types of colorectal cancer. ... 2010, the annual meeting of the American Gastroenterological Association. ... cause of cancer deaths among women in the United ...
... cuts the needed pre-procedure liquid intake in half, study says, ... people dread a colonoscopy is the unpleasant preparation, which often ... clear out their bowels before the procedure. But an industry-funded ... so much liquid. , Researchers from Henry Ford Hospital report ...
... MAY 2, 2010 The American Society for Gastrointestinal ... endoscopy during the sixth annual ASGE Crystal Awards on Sunday, ... this year,s event will begin at 6:30 p.m. at the ... with Digestive Disease Week (DDW), the ASGE Crystal Awards symbolize ...
... side, requiring colonoscopy for detection, study says , SUNDAY, May 2 ... women to have colon polyps and are also more likely to ... , The researchers also found that the study patients older than ... younger than 60. , Polyps are growths in the large intestine. ...
Cached Medicine News:Health News:Researchers make advances in understanding causes, treatments and outcomes of liver disease 2Health News:Researchers make advances in understanding causes, treatments and outcomes of liver disease 3Health News:Researchers make advances in understanding causes, treatments and outcomes of liver disease 4Health News:Researchers make advances in understanding causes, treatments and outcomes of liver disease 5Health News:Researchers make advances in understanding causes, treatments and outcomes of liver disease 6Health News:Researchers make advances in understanding causes, treatments and outcomes of liver disease 7Health News:Designer Makeover for a New Resident at Westmont of Morgan Hill 2Health News:Older women with diabetes face higher risk for colon cancer 2Health News:Colonoscopy Prep in a Pill May Be Easier to Swallow 2Health News:ASGE and ASGE Foundation hold Crystal Awards dinner at Digestive Disease Week 2Health News:ASGE and ASGE Foundation hold Crystal Awards dinner at Digestive Disease Week 3Health News:ASGE and ASGE Foundation hold Crystal Awards dinner at Digestive Disease Week 4Health News:ASGE and ASGE Foundation hold Crystal Awards dinner at Digestive Disease Week 5Health News:ASGE and ASGE Foundation hold Crystal Awards dinner at Digestive Disease Week 6Health News:ASGE and ASGE Foundation hold Crystal Awards dinner at Digestive Disease Week 7Health News:Colon Polyps More Common in Hispanic Men Than Women 2